Bright Minds Biosciences
DRUG
#7511
Rank
A$0.43 B
Marketcap
$62.41
Share price
1.73%
Change (1 day)
3,100.81%
Change (1 year)

Earnings for Bright Minds Biosciences (DRUG)

Earnings in 2024 (TTM): -A$4.08 Million

According to Bright Minds Biosciences's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -A$7.84 Million, an increase over its 2022 earnings that were of -A$14.8 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Bright Minds Biosciences from 2020 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$4.08 Million-48.05%
2023 -A$7.84 Million-47.01%
2022 -A$14.8 Million-7.16%
2021 -A$15.94 Million1162.81%
2020 -A$1.27 Million